Cannabis

The Oct. 9 filing follows a July deal to issue 0.015383618 Vireo share per eligible Planet 13 share, subject to shareholder and regulatory approvals.

The Oct. 8 cash deal lifts its Canadian network to 234 stores, including 93 in Alberta, and the shop is set to become a Canna Cabana.

The developer awaits new tariff terms from state utility ANDE for Villeta, its US$665M green fertiliser development.

The Oct. 8 preliminary Form F-3 covers note conversions and warrants; selling holders would receive proceeds from resales.

A property memorandum links a Washington Avenue retail renovation to Trulieve TX Inc.; a Texas accessibility review does not authorize cannabis sales.

The Oct. 6 departure took effect immediately, while SNDL's board page still listed Cannell among seven directors on Oct. 7.

Saxony-Anhalt licensed new production areas in Leuna, but Aurora gave no tonnage or timetable for deliveries from the expanded site.

Gross margin widened to 30 per cent, but cannabis revenue declined; Tilray retained its fiscal 2027 adjusted EBITDA target.

Trulieve's Oct. 7 release says notes secured by its Jefferson County cultivation site were repaid, leaving about US$225M of debt.

The live application separates medical marijuana manufacturers, distributors and labs; state licences remain a condition of registration.

The Oct. 5 rule caps adult-use edibles at 10 milligrams per serving and 100 milligrams per package; medical edibles have higher caps.

An Oct. 6 SEC amendment identifies a SEDAR+ notice changing the bid's consideration and expiry after Curaleaf announced new cash and share terms.

The 8.5 per cent property loan matures in April 2034 and puts cultivation sites in Johnstown and Palatka behind the debt.

The special committee will review formal materials before the board recommends a response; shareholders were told to take no action.

The Quebec grower has 15 of 24 Valleyfield rooms active and is still pursuing EU-GMP certification for its own processing centre.

The planned notice would lift cash to US$1 and the cap to US$6 per share, and extend the current Dec. 1 expiry to Dec. 4.

The Sept. 29 plan gives cannabis operators no deadline or estimate of tax relief as the guidance project enters the new fiscal year.

Congress delayed the new 0.4-milligram finished-product threshold to Dec. 11, leaving Tilray's disclosed U.S. drink formats above it.

State approvals cleared the Oct. 1 transfer of certain Ohio operations; AYR disclosed no cash proceeds or debt relief figure.

One petition is active and the other pending review; both would let Florida medical operators sell to adults if voters approve.

The ARTG's Sept. 15 entry names Jupiter Research as manufacturer; Curaleaf also reports a Sept. 17 New Zealand WAND notification.

Colorado completed its review on Sept. 29; permit issuance requires verified warranties, and DOE mine-plan approval remains pending.

The uncontrolled Canadian trial enrolled 11 patients; seven were evaluable for pain, and validated data analysis remains underway.

Lifted Made closed the Kenosha building sale Sept. 29 and used US$841,110 to repay all its outstanding bank debt.

A Sept. 29 stay in DEA hearing docket 26-96 sets Oct. 13 for a response to a motion seeking to add the GAO report to the record.

Holders have until Oct. 23 to vote on one new share for five to 15 existing shares, nomination rules and incentive-plan entitlements.

Battle Green can require a share-funded note purchase, while Vireo can trigger one at a lower share price; the maturity route uses a future trading average.

IMC Holdings retains liabilities under a C$9.4M cap subject to mutual adjustment; direct subsidiary debts are excluded from that cap.

The cannabis banking platform expects SHFS to keep its Nasdaq ticker and round fractional holdings up when split-adjusted trading begins Sept. 30.

The perpetual, royalty-free agreement covers two brands, while a Texas launch still requires final state licensure and regulatory approval.

Blöte starts Oct. 1 as Canopy seeks German medical cannabis growth; its June quarter international cannabis revenue was C$9.6M.

The Sept. 25 charter amendment doubles common-share capacity and raises the cannabis landlord’s preferred-share ceiling without a shareholder vote.

The Sept. 25 meeting lacked quorum, leaving shareholders until 9 a.m. EDT on Oct. 23 to submit proxies before the reconvened vote.

Holders will weigh a new parent company, a Delaware move and a voting-share sunset extension as Cresco pursues a potential U.S. listing.